Search results for "COD"

showing 10 items of 2985 documents

Predictability of pharmaceutical spending in primary health services using Clinical Risk Groups

2014

Background: Risk adjustment instruments applied to existing electronic health records and administrative datasets may contribute to monitoring the correct prescribing of medicines. Objective: We aim to test the suitability of the model based on the CRG system and obtain specific adjusted weights for determined health states through a predictive model of pharmaceutical expenditure in primary health care. Methods: A database of 261,054 population in one health district of an Eastern region of Spain was used. The predictive power of two models was compared. The first model (ATC-model) used nine dummy variables: sex and 8 groups from 1 to 8 or more chronic conditions while in the second model (…

MaleECONOMIA APLICADAHealth StatusPopulationContext (language use)Pharmacy expenditureDrug CostsSex FactorsDrug TherapyDummy variablePrimary healthMedicineHumansPredictabilityeducationeducation.field_of_studyActuarial scienceModels StatisticalPrimary Health Carebusiness.industryHealth PolicyClinical Risk GroupsAge FactorsECONOMIA SOCIOLOGIA Y POLITICA AGRARIATest (assessment)Risk adjustmentOne HealthSpainChronic DiseasePredictive powerFemalebusinessWHO-ATC-Code
researchProduct

Interrogator intonation and memory encoding performance.

2019

Based on recent findings that interrogator intonation can enhance interrogative suggestibility during recall phases, the present study tested influences of interrogator intonation on memory performance even as early as at the encoding stage. We experimentally manipulated interrogator intonation during encoding of a story to be recalled in immediate and delayed subsequent memory tests (Experiment 1, N = 50). As expected, a symmetrically structuring vs. an isolating-emphasizing speaking style generally increased the amount of freely recalled details. In a more fine-grained experiment (N = 50), we additionally manipulated emphasized story details and tested recall rates for peripheral, neutral…

MaleEmotionsSocial SciencesCognitionLearning and MemoryHearingMedicine and Health SciencesPsychologyInterrogationPitch PerceptionLanguageGrammarMultidisciplinary05 social sciencesQRCognitionSyllablesClinical Laboratory SciencesMemory RecallEngineering and TechnologyMedicineSensory PerceptionFemalePsychologyCognitive psychologyResearch ArticleAdultSciencePhonologyEffect Modifier Epidemiologic050105 experimental psychologyYoung AdultMemoryDiagnostic MedicineEncoding (memory)SpeechHumans0501 psychology and cognitive sciencesRelevance (information retrieval)0505 lawForensicsRecallVerbal BehaviorSuggestibilityIntonation (linguistics)Cognitive PsychologyBiology and Life SciencesLinguisticsInterrogativeSpeech Signal ProcessingSignal ProcessingMental Recall050501 criminologyCognitive ScienceLaw and Legal SciencesNeurosciencePLoS ONE
researchProduct

Time-resolved classification of dog brain signals reveals early processing of faces, species and emotion

2020

Dogs process faces and emotional expressions much like humans, but the time windows important for face processing in dogs are largely unknown. By combining our non-invasive electroencephalography (EEG) protocol on dogs with machine-learning algorithms, we show category-specific dog brain responses to pictures of human and dog facial expressions, objects, and phase-scrambled faces. We trained a support vector machine classifier with spatiotemporal EEG data to discriminate between responses to pairs of images. The classification accuracy was highest for humans or dogs vs. scrambled images, with most informative time intervals of 100–140 ms and 240–280 ms. We also detected a response sensitive…

MaleEmotionslcsh:MedicinehavaitseminenperceptionFAMILIAR413 Veterinary scienceBehavioural methodsMachine Learningsocial behaviourEXPRESSIONSAnimal physiologyEVOKED-POTENTIALSEEGNeural decodingvertaileva psykologialcsh:Sciencesocial evolutionVisual CortexSocial evolutionelectroencephalography – EEGElectroencephalographyAnimal behaviourPublisher Correctionneural decodinganimal physiologySocial behaviourFemalesosiaalinen käyttäytyminenihminen-eläinsuhdeFacial RecognitionERPElectroencephalography - EEGanimal behaviourevoluutioemotionEVENT-RELATED POTENTIALSkoiraeläinten käyttäytyminenArticleDogsSpatio-Temporal AnalysistunteetAnimalsEmotionlcsh:RATTENTIONDISCRIMINATIONPROJECTIONSPerceptionlcsh:QPhotic Stimulationbehavioural methodsRESPONSESScientific Reports
researchProduct

Semi-mechanistic Pharmacokinetic/Pharmacodynamic model of three pegylated rHuEPO and ior®EPOCIM in New Zealand rabbits.

2018

Abstract Marketed formulations of erythropoietin (EPO) ior®EPOCIM, MIRCERA® and two newly developed pegylated-EPO analogues (PEG-EPO 32 and 40 kDa) formulations were intravenously administered to New Zealand rabbits. A semi-mechanistic Pharmacokinetic/Pharmacodynamic (PK/PD) model describing in a simultaneous and integrated form the time course of reticulocytes, red blood cells and hemoglobin was built to account for the time course of hematopoiesis stimulation after erythropoietin administration. Data analysis was performed based on the population approach with the software NONMEM version 7.3. Erythropoietin disposition of each of the administered formulations was best described with a two…

MaleErythrocytesReticulocytesDrug CompoundingPopulationPharmaceutical ScienceBiological AvailabilityPharmacology030226 pharmacology & pharmacyModels BiologicalPolyethylene Glycols03 medical and health sciencesHemoglobins0302 clinical medicinePharmacokineticshemic and lymphatic diseasesMedicineAnimalseducationErythropoietinVolume of distributioneducation.field_of_studybusiness.industryRecombinant ProteinsNONMEMHematopoiesisHaematopoiesisErythropoietin030220 oncology & carcinogenesisPharmacodynamicsInjections IntravenousHematinicsLinear ModelsHemoglobinRabbitsbusinessmedicine.drugEuropean journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
researchProduct

Attenuation of disease phenotype through alternative translation initiation in low-penetrance retinoblastoma

2006

Hereditary predisposition to retinoblastoma (RB) is caused by germline mutations in the retinoblastoma 1 (RB1) gene and transmits as an autosomal dominant trait. In the majority of cases disease develops in greater than 90% of carriers. However, reduced penetrance with a large portion of disease-free carrier is seen in some families. Unambiguous identification of the predisposing mutation in these families is important for accurate risk prediction in relatives and their genetic counseling but also provides conceptual information regarding the relationship between the RB1 genotype and the disease phenotype. In this study we report a novel mutation detected in 10 individuals of an extended fa…

MaleGenotypeDNA Mutational AnalysisGreen Fluorescent ProteinsMolecular Sequence DataPenetranceBiologyRetinoblastoma ProteinFrameshift mutationExonGermline mutationGeneticsmedicineHumansGenetic Predisposition to DiseaseAmino Acid SequenceRNA MessengerChildFrameshift MutationPeptide Chain Initiation TranslationalGenetics (clinical)GeneticsRetinoblastomaRetinoblastomaInfantAutosomal dominant traitExonsmedicine.diseasePenetranceAlternative SplicingPhenotypeCodon NonsenseHereditary RetinoblastomaMutation (genetic algorithm)FemaleHuman Mutation
researchProduct

Functional analysis of splicing mutations in MYO7A and USH2A genes.

2010

Usher syndrome is defined by the association of sensorineural hearing loss, retinitis pigmentosa and variable vestibular dysfunction. Many disease-causative mutations have been identified in MYO7A and USH2A genes, which play a major role in Usher syndrome type I and type II, respectively. The pathogenic nature of mutations that lead to premature stop codons is not questioned; nevertheless, additional studies are needed to verify the pathogenicity of some changes such as those putatively involved in the splice process. Five putative splice-site variants were detected in our cohort of patients: c.2283-1G>T and c.5856G>A in MYO7A and c.1841-2A>G, c.2167+5G>A and c.5298+1G>C in the USH2A gene. …

MaleGenotypeUsher syndromeRNA SplicingBiologyMyosinsmedicine.disease_causeExonChlorocebus aethiopsGene OrderGeneticsmedicineotorhinolaryngologic diseasesAnimalsHumansspliceGeneGenetics (clinical)GeneticsMutationExtracellular Matrix Proteinsmedicine.diseaseStop codonMyosin VIIaRNA splicingCOS CellsMutationFemaleRNA Splice SitesUsher SyndromesMinigeneClinical genetics
researchProduct

A novel mutation of gene CBFA1/RUNX2 in cleidocranial dysplasia.

2007

Cleidocranial dysplasia (CCD) is an autosomal dominant skeletal dysplasia characterised by abnormal clavicles, patent sutures and fontanelles, supernumerary teeth, short stature, and a variety of other skeletal changes. The disease gene is CBFA1/RUNX2, which is mapped to chromosome 6p21. Inactivation of the CBFA1/RUNX2 gene by mutations is involved in the skeletal defects that occur in patients with CCD. CBFA1/RUNX2 controls the differentiation of precursor cells into osteoblasts and is essential for membranous as well as endochondral bone formation. In this study of a 14-yr-old boy with typical CCD phenotype, the authors found a novel CBFA1/RUNX2 gene mutation. All of the amplified segment…

MaleHeterozygoteAdolescentDNA Mutational AnalysisCore Binding Factor Alpha 1 SubunitPolymerase Chain ReactionPedigreeAdolescent Chromosomes Human Pair 6 Cleidocranial Dysplasia/genetics* Cleidocranial Dysplasia/pathology Codon Nonsense/genetics* Core Binding Factor Alpha 1 Subunit/genetics* DNA Mutational Analysis DNA Primers/chemistry Female Gene Silencing Heterozygote Humans Male Pedigree Point Mutation* Polymerase Chain Reactioncleidocranial dysplasiaCodon NonsenseCBFA1/RUNX2HumansPoint MutationChromosomes Human Pair 6Femalegene mutationGene SilencingCleidocranial DysplasiaDNA Primers
researchProduct

Multiple identification of a particular type of hereditary C1q deficiency in the Turkish population: review of the cases and additional genetic and f…

1997

Complete selective deficiencies of the complement component C1q are rare genetic disorders that are associated with recurrent infections and a high prevalence of lupus erythematosus-like symptoms. All C1q deficiencies studied at the genetic level revealed single-base mutations leading to termination codons, frameshifts or amino acid exchanges and these were thought to be responsible for the defects as no other aberrations were found. One particular mutation, leading to a stop codon in the C1qA gene, was first identified in members of a Gypsy family from the Slovak Republic. The same mutation has been found in all cases of C1q deficiency from Turkey that have been investigated. Here we prese…

MaleHeterozygoteSlovakiaTurkish populationRomaTurkeyGenetic counselingMolecular Sequence DataPopulationBiologyPolymerase Chain ReactionGenetic analysisGeneticsHumansPoint MutationAmino Acid SequenceeducationGeneGenetics (clinical)Geneticseducation.field_of_studyBase SequenceComplement C1qImmunologic Deficiency SyndromesHuman geneticsStop codonPedigreeChild PreschoolMutation (genetic algorithm)Codon TerminatorFemalePolymorphism Restriction Fragment LengthHuman Genetics
researchProduct

Involvement of Dopamine D2 Receptors in Addictive-Like Behaviour for Acetaldehyde

2014

Acetaldehyde, the first metabolite of ethanol, is active in the central nervous system, where it exerts motivational properties. Acetaldehyde is able to induce drinking behaviour in operant-conflict paradigms that resemble the core features of the addictive phenotype: drug-intake acquisition and maintenance, drug-seeking, relapse and drug use despite negative consequences. Since acetaldehyde directly stimulates dopamine neuronal firing in the mesolimbic system, the aim of this study was the investigation of dopamine D2-receptors' role in the onset of the operant drinking behaviour for acetaldehyde in different functional stages, by the administration of two different D2-receptor agonists, q…

MaleIndoleslcsh:MedicinePharmacologyBehavioral Neurosciencechemistry.chemical_compoundquinpiroleMedicine and Health Scienceslcsh:ScienceNeuropharmacologyDrug DependenceMultidisciplinaryDopaminergicD2 dopamine receptorsAcetaldehyde; Operant self-administration; D2 dopamine receptors; quinpiroleNeurologyBehavioral PharmacologyDopamine AgonistsSignal TransductionResearch Articlemedicine.drugAlcohol DrinkingDrug-Seeking BehaviorAcetaldehydeAddictive-Like BehaviourNeuropharmacologyQuinpiroleDopamineDopamine receptor D2medicineAnimalsRats WistarAcetaldehyde; Addictive-Like Behaviour; Dopamine D2 ReceptorsPharmacologyOperant self-administrationEthanolReceptors Dopamine D2Neurotransmissionlcsh:RAcetaldehydeBiology and Life SciencesDopamine D2 ReceptorsRatsRopinirolePharmacodynamicschemistrySettore BIO/14 - FarmacologiaConditioning Operantlcsh:QNeurosciencePLoS ONE
researchProduct

DALI: Defining Antibiotic Levels in Intensive Care Unit Patients: Are Current -Lactam Antibiotic Doses Sufficient for Critically Ill Patients?

2014

Background. Morbidity and mortality for critically ill patients with infections remains a global healthcare problem. We aimed to determine whether α-lactam antibiotic dosing in critically ill patients achieves concentrations associated with maximal activity and whether antibiotic concentrations affect patient outcome.Methods. This was a prospective, multinational pharmacokinetic point-prevalence study including 8 α-lactam antibiotics. Two blood samples were taken from each patient during a single dosing interval. The primary pharmacokinetic/pharmacodynamic targets were free antibiotic concentrations above the minimum inhibitory concentration (MIC) of the pathogen at both 50% (50% f TMIC) an…

MaleInternational CooperationAntibioticsadverse eventintensive care unitlaw.invention0302 clinical medicinemeropenemModels[SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseasesadverse events; continuous infusion; extended infusion; pharmacodynamics; pharmacokinetics; Aged; Anti-Bacterial Agents; Bacterial Infections; Blood Chemical Analysis; Female; Humans; Intensive Care Units; International Cooperation; Male; Microbial Sensitivity Tests; Middle Aged; Models Statistical; Prospective Studies; Treatment Outcome; beta-Lactams; Critical Illnessantibiotic therapyProspective Studiesamoxicillin plus clavulanic acidComputingMilieux_MISCELLANEOUSbeta lactam antibioticAPACHE0303 health sciencescritical illneadultclinical trial3. Good healthcontinuous infusion; extended infusion; adverse events; pharmacokinetics; pharmacodynamics.antiinfective agent[SDV.MP]Life Sciences [q-bio]/Microbiology and Parasitologypriority journaldisease severitybeta-Lactamstatistical model Agedprospective studyHumanMicrobiology (medical)medicine.medical_specialtydrug exposureCritical IllnessImmunologybloodstream infectionMicrobial Sensitivity Testspiperacillin plus tazobactambeta-LactamsMicrobiologybeta lactam abdominal infection03 medical and health sciencescritically ill patientIntensive careAnti-Bacterial AgentcefepimepharmacodynamicsHumansDosingAdverse effectAgedModels Statistical030306 microbiologyOdds ratiomajor clinical studymortalityantibiotic sensitivityceftriaxoneProspective Studiemulticenter studypharmacodynamics.ampicillinBlood Chemical AnalysisCeftazidimeSettore MED/41 - AnestesiologiaInterquartile rangelaw030212 general & internal medicinepharmacokineticlung infectionMicrobial Sensitivity TestarticleBacterial InfectionsMiddle AgedStatisticalcontinuous infusionIntensive care unitAnti-Bacterial Agentsextended infusionIntensive Care UnitsInfectious DiseasesTreatment Outcomeadverse events; continuous infusion; extended infusion; pharmacodynamics; pharmacokinetics; Aged; Anti-Bacterial Agents; Bacterial Infections; Blood Chemical Analysis; Female; Humans; Intensive Care Units; International Cooperation; Male; Microbial Sensitivity Tests; Middle Aged; Models Statistical; Prospective Studies; Treatment Outcome; beta-Lactams; Critical Illness; Microbiology (medical); Infectious Diseasescefazolin[SDV.IMM]Life Sciences [q-bio]/Immunologyblood samplingFemalepharmacokineticsmedicine.drugmedicine.drug_classprevalencedoripenemminimum inhibitory concentrationBacterial InfectionInternal medicinemedicinecontrolled studyblood analysibusiness.industryBlood Chemical Analysiadverse eventsSurgerypharmacodynamicdrug blood levelbusiness
researchProduct